News | April 30, 2015

Proton Partners International Announces Partnerships to Equip U.K.’s First Proton Beam Therapy Centers

IBA, Philips to supply proton therapy system and treatment planning software, respectively, to three locations

Proton Partners International, proton beam therapy centers, UK, IBA, Philips

April 30, 2015 — Proton Partners International Limited announced the appointment of global partners in its plans to build three proton beam therapy centers in the U.K. Partner organizations will provide state-of-the-art clinical equipment and technology solutions to the company.

Proton Partners International Ltd is to open treatment centers in Cardiff, London and Northumbria by 2017 and the first - Cardiff - will be operational next year. The establishment of the centers will mark a significant breakthrough in the provision of cancer treatment in the U.K. The lack of access to the latest radiotherapy treatment options in the U.K. has been highlighted in a flood of patient dramas in the press. Proton therapy hit the headlines when the delay in provision of machines in the National Health Service (NHS) led to many patients, acknowledged to need proton therapy, being transported to the U.S. and elsewhere for treatment, which unsurprisingly is much more costly than could be available in the U.K.

IBA (Ion Beam Applications) has been selected by Proton Partners to install its single-room proton therapy system, Proteus One, in each of the three U.K. centers.

Philips has been appointed to deliver software and technology tools including Philips' Pinnacle Treatment Planning, which delivers an intuitive planning environment that simplifies workflow. Philips will also provide big bore computed tomography (CT) scanners at each centre and a positron emission tomography (PET/CT) in the Cardiff center.

Before appointing its suppliers, Proton Partners International conducted an exhaustive selection process across two continents, including visiting the Willis Knighton Hospital in Shreveport, Louisiana, to see an IBA treatment room in operation. Final selection was made on technical and commercial merit.

Prof. Gordon McVie, senior consultant at the European Institute of Oncology and chairman of Proton Partners International, said: "These appointments are a significant milestone along the pathway to establishing the first proton beam therapy centers in the UK and reflect the quality and strength of our commitment to improve cancer treatment."

For more information:

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more